Evidence map›Paper›PMID 34393643›Full record

ArticleActa medica Lituanic2021

Ollier Disease: A Case Series and Literature Review.

Vėtra Markevičiūtė, Medeinė Šilenė Markevičiūtė, Mindaugas Stravinskas

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Acta medica Lituanic, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Disastrous evolution of ollier disease: a rare case report.Annals of medicine and surgery (2012) · 2023
    Article
  6. Article
  7. Benign cartilaginous tumors of the hand, a five-year retrospective study.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Vėtra MarkevičiūtėDepartment of Orthopaedics and Traumatology, Lithuanian University of Health Sciences, Kauno klinikos, Kaunas, Lithuania.
Medeinė Šilenė MarkevičiūtėFaculty of Medicine, Vilnius University, Vilnius, Lithuania.
Mindaugas StravinskasDepartment of Orthopaedics and Traumatology, Lithuanian University of Health Sciences, Kauno klinikos, Kaunas, Lithuania.
Lithuanian University of Health Sciences · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SUMMARY

backgroundOllier disease is the most common nonhereditary type of enchondromatosis. Enchondromas are common, usually benign intraosseous cartilaginous tumors that form near the growth plate cartilage predominantly unilaterally in the metaphyses and diaphyses of tubular bones. They usually affect the long bones of the hand, the humerus, and the tibia, followed by flat bones, such as the pelvis. The estimated prevalence of Ollier disease is 1 in 100,000 and while it is linked with somatic heterozygous mutations in IDH1 or IDH2 genes, exact etiology is unknown. The risk of malignant transformation towards chondrosarcoma is up to 30-35% and it is clinically suspected when pain and a rapid increase in the size of the lesions is seen. CASE PRESENTATIONS: We report two clinical cases of patients diagnosed with Ollier disease. In both cases transformation to chondrosarcoma was observed.

conclusionsOllier disease is a rare disorder, defined by the presence of multiple enchondromas and an asymmetric distribution of the cartilage lesions that can be extremely variable in terms of size, location, age, gender. Constant monitoring of patients is important due to the high risk of malignancy. Because the disease is very rare and the manifestations vary widely, each patient's case must be evaluated, and the treatment strategy adopted individually.

Indexed as

chondrosarcomaechondromatosisenchondromaOllier disease

Identifiers

PMID34393643
PMCPMC8311836
OpenAlexW3130150458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.